Trilogy Health Services CMO discusses Medicare Advantage's impact on skilled nursing, focusing on administrative challenges, appeals, and value-based care opportunities. Insights on I-SNP partnerships and payment simplification for providers.
Medicare Advantage expansion is linked to care delays in skilled nursing facilities, urging providers to better understand MA protocols for improved patient outcomes.
FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.
The Trump administration's WISeR pilot program introduces AI-driven prior authorization in Medicare to reduce waste and fraud, raising concerns over patient care and regulatory oversight.
Explore how AI-powered predictive analytics improve diabetes management and reduce Medicare costs through personalized patient adherence interventions.
Medicare telehealth waivers enabling expanded coverage during COVID-19 expire in 2025. Providers must prepare for significant Medicare and regulatory changes affecting telehealth reimbursement and compliance.
The Trump administration's $100,000 H-1B visa fee poses challenges for the healthcare workforce, especially in rural areas, amid hospital closures, regulatory penalties, and healthcare market shifts.
TailorCare extends its value-based musculoskeletal care program to Humana Medicare Advantage members in Dallas and Denver, enhancing personalized care coordination and outcomes.
Medicare Advantage incurs a $5.7 billion underwriting loss in 2024 due to increased utilization, medical inflation, and regulatory changes, impacting insurer profitability and market dynamics.
SelectQuote Inc. faces a DOJ whistleblower lawsuit over Medicare Advantage sales practices, triggering stock declines and investor class-action suits. Key updates on regulatory compliance and market impact.
